Fundamentals of FGF19 & FGF21 action in vitro and in vivo

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Adams, Andrew C ^a   Coskun, Tamer ^a   Rovira, Armando R ^a   Schneider, Michael A ^a   Raches, David W ^a   Micanovic, Radmila ^a   Bina, Holly A ^a   Dunbar, James D ^a   Kharitonenkov, Alexei ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 19; FIBROBLAST GROWTH FACTOR 21; FIBROBLAST GROWTH FACTOR 21 DELTAN17; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 3; FIBROBLAST GROWTH FACTOR RECEPTOR 4; GLUCOSE; KLOTHO BETA PROTEIN; KLOTHO PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; BETA GLUCURONIDASE; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 15, MOUSE; FIBROBLAST GROWTH FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL CULTURE; CELL PROLIFERATION; CONTINUOUS INFUSION; CONTROLLED STUDY; ENERGY BALANCE; ENERGY METABOLISM; ENZYME PHOSPHORYLATION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER PARENCHYMA; MALE; MITOGENICITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; RECEPTOR BINDING; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CELL LINE; DRUG EFFECT; EATING; LIVER CELL; METABOLISM;

MUS;

ANIMALS; BODY WEIGHT; CELL LINE; CELL PROLIFERATION; EATING; FIBROBLAST GROWTH FACTORS; GLUCURONIDASE; HEPATOCYTES; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 84861657962     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038438     Document Type: Article

References (42)

1. Yeoh JS, de Haan G, (2007) Fibroblast growth factors as regulators of stem cell self-renewal and aging. Mech Ageing Dev 128: 17-24.
2. Chen GJ, Forough R, (2006) Fibroblast growth factors, fibroblast growth factor receptors, diseases, and drugs. Recent Pat Cardiovasc Drug Discov 1: 211-224.
3. Kharitonenkov A, (2009) FGFs and metabolism. Curr Opin Pharmacol 9: 805-810.
4. Kurosu H, Kuro-o M, (2008) The Klotho gene family and the endocrine fibroblast growth factors. Curr Opin Nephrol Hypertens 17: 368-372.
5. Wu X, Ge H, Gupte J, Weiszmann J, Shimamoto G, et al. (2007) Co-receptor requirements for fibroblast growth factor-19 signaling. J Biol Chem 282: 29069-29072.
6. Kharitonenkov A, Dunbar JD, Bina HA, Bright S, Moyers JS, et al. (2008) FGF-21/FGF-21 receptor interaction and activation is determined by betaKlotho. J Cell Physiol 215: 1-7.
7. Itoh N, (2010) Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease. Cell Tissue Res 342: 1-11.
8. Kuro-o M, (2010) Overview of the FGF23-Klotho axis. Pediatr Nephrol 25: 583-590.
9. Long YC, Kharitonenkov A, (2011) Hormone-like fibroblast growth factors and metabolic regulation. Biochim Biophys Acta 1812 791-795.
10. Coskun T, Bina HA, Schneider MA, Dunbar JD, Hu CC, et al. (2008) Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 149: 6018-6027.
11. Wu X, Ge H, Lemon B, Weiszmann J, Gupte J, et al. (2009) Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice. Proc Natl Acad Sci U S A 106: 14379-14384.
12. Huang X, Yang C, Luo Y, Jin C, Wang F, et al. (2007) FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver. Diabetes 56: 2501-2510.
13. Micanovic R, Raches DW, Dunbar JD, Driver DA, Bina HA, et al. (2009) Different roles of N- and C- termini in the functional activity of FGF21. J Cell Physiol 219: 227-234.
14. Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, et al. (2005) FGF-21 as a novel metabolic regulator. J Clin Invest 115: 1627-1635.
15. Crissman JW, Goodman DG, Hildebrandt PK, Maronpot RR, Prater DA, et al. (2004) Best practices guideline: toxicologic histopathology. Toxicol Pathol 32: 126-131.
16. Moyers JS, Shiyanova TL, Mehrbod F, Dunbar JD, Noblitt TW, et al. (2007) Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling. J Cell Physiol 210: 1-6.
17. Fisher FM, Estall JL, Adams AC, Antonellis PJ, Bina HA, et al. (2011) Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo. Endocrinology 152: 2996-3004.
18. Wu X, Ge H, Lemon B, Vonderfecht S, Weiszmann J, et al. (2010) FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation. J Biol Chem 285: 5165-5170.
19. Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, et al. (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444: 770-774.
20. Wu X, Ge H, Lemon B, Vonderfecht S, Baribault H, et al. (2010) Separating mitogenic and metabolic activities of fibroblast growth factor 19 (FGF19). Proc Natl Acad Sci U S A 107: 14158-14163.
21. Nicholes K, Guillet S, Tomlinson E, Hillan K, Wright B, et al. (2002) A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice. Am J Pathol 160: 2295-2307.
22. Kharitonenkov A, Larsen P, (2011) FGF21 reloaded: challenges of a rapidly growing field. Trends Endocrinol Metab 22: 81-86.
23. Kharitonenkov A, Shanafelt AB, (2008) Fibroblast growth factor-21 as a therapeutic agent for metabolic diseases. BioDrugs 22: 37-44.
24. Fu L, John LM, Adams SH, Yu XX, Tomlinson E, et al. (2004) Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. Endocrinology 145: 2594-2603.
25. Kurosu H, Kuro OM, (2009) The Klotho gene family as a regulator of endocrine fibroblast growth factors. Mol Cell Endocrinol 299: 72-78.
26. Wu X, Lemon B, Li X, Gupte J, Weiszmann J, et al. (2008) C-terminal tail of FGF19 determines its specificity toward Klotho co-receptors. J Biol Chem 283: 33304-33309.
27. Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, et al. (2006) Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem 281: 6120-6123.
28. Tomiyama K, Maeda R, Urakawa I, Yamazaki Y, Tanaka T, et al. (2010) Relevant use of Klotho in FGF19 subfamily signaling system in vivo. Proc Natl Acad Sci U S A 107: 1666-1671.
29. Kurosu H, Choi M, Ogawa Y, Dickson AS, Goetz R, et al. (2007) Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J Biol Chem 282: 26687-26695.
30. Potthoff MJ, Inagaki T, Satapati S, Ding X, He T, et al. (2009) FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. Proc Natl Acad Sci U S A 106: 10853-10858.
31. Wu X, Weiszmann J, Ge H, Baribault H, Stevens J, et al. (2012) A Unique FGF23 with the Ability to Activate FGFR Signaling through Both alphaKlotho and betaKlotho. J Mol Biol 418: 82-89.
32. Ogawa Y, Kurosu H, Yamamoto M, Nandi A, Rosenblatt KP, et al. (2007) BetaKlotho is required for metabolic activity of fibroblast growth factor 21. Proc Natl Acad Sci U S A 104: 7432-7437.
33. Goetz R, Ohnishi M, Ding X, Kurosu H, Wang L, et al. (2012) Klotho Co-Receptors Inhibit Signaling by Paracrine FGF8 Subfamily Ligands. Mol Cell Biol.
34. Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, et al. (2007) Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab 5: 426-437.
35. Inagaki T, Dutchak P, Zhao G, Ding X, Gautron L, et al. (2007) Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab 5: 415-425.
36. Hale C, Chen MM, Stanislaus S, Chinookoswong N, Hager T, et al. (2012) Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance. Endocrinology 153: 69-80.
37. Fisher FM, Chui PC, Antonellis PJ, Bina HA, Kharitonenkov A, et al. (2010) Obesity is a fibroblast growth factor 21 (FGF21)-resistant state. Diabetes 59: 2781-2789.
38. Motoda N, Matsuda Y, Onda M, Ishiwata T, Uchida E, et al. (2011) Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma. Int J Oncol 38: 133-143.
39. Roidl A, Berger HJ, Kumar S, Bange J, Knyazev P, et al. (2009) Resistance to chemotherapy is associated with fibroblast growth factor receptor 4 up-regulation. Clin Cancer Res 15: 2058-2066.
40. Wu AL, Coulter S, Liddle C, Wong A, Eastham-Anderson J, et al. (2011) FGF19 regulates cell proliferation, glucose and bile acid metabolism via FGFR4-dependent and independent pathways. PLoS One 6: e17868.
41. Suzuki M, Uehara Y, Motomura-Matsuzaka K, Oki J, Koyama Y, et al. (2008) betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c. Mol Endocrinol 22: 1006-1014.
42. Badman MK, Kennedy AR, Adams AC, Pissios P, Maratos-Flier E, (2009) A Very Low Carbohydrate Ketogenic Diet Improves Glucose Tolerance in ob/ob Mice Independent of Weight Loss. Am J Physiol Endocrinol Metab.